/
/
Working Groups

Working Groups

WG1 - Network Promotion

Networking, management, dissemination issues, assessment of work plan and sustainability

Objectives

RC3. Raising general awareness of the impact of adverse events on healthcare professionals (considering gender differences) and their consequences in personal, professional, social, legal, economic, and labour terms.

RC5. Understanding of the causes of clinical errors disseminating the results of the research and experiences to stakeholders (patient associations, professional societies, trade unions, healthcare manager associations, policy makers) and the general public.

CB3. To provide a platform to develop a research and implementation agenda involving relevant stakeholders in the healthcare context to promote effective solutions and facilitate discussion of the legal, ethical, social, and organisational issues.

Deliverables

– Website
– Corporative Image
– Annual and Final Reports
– Final Technical Report

Members

Anabela Coelho

Directorate-General of Health [Department of Quality in Health]

Portugal

Andres Fontalba Navas

Malaga North Health Area

Spain

Ceyda Uzun Şahin

Ceyda Uzun Şahin

Department of Vocational School of Health Services, Recep Tayyip Erdoğan University, Rize

Turkey

Daniel Moreno Sanjuán

Daniel Moreno Sanjuán

Andalusian Health Service in PICUIDA team and Malaga University

Spain

Irada Khalilova

Khazar University

Azerbaijan

Ivana Skoumalova

Ivana Skoumalova

Pavol Jozef Safarik University

Slovakia

José Carlos Canca Sánchez

Spain

José Joaquín Mira

José Joaquín Mira

Action Chair

Fundacion para el fomento de la investigación sanitaria y biomédica de la comunitat valenciana

SPAIN

Marius-Ionut Ungureanu

Marius-Ionut Ungureanu

WG1 Leader

Department of Public Health, Babeș-Bolyai University

ROMANIA

Ümit Atabek

Turkey

Valter R. Fonseca

Faculty of Medicine, University of Lisbon

Portugal

WG2 - Review and description of the State-of-the-Art

Review and disseminate conceptualization, evidence-based interventions, metrics and instruments, including the experiences from other industries

Objectives

RC1. Encouraging discussion of the meaning of the fourth criterion (Quadruple Aim) and its implications for healthcare organisations.

RC2. Further developing the theoretical conceptualisation of the second victim phenomenon and developing a common understanding of its definition.

RC9. Learning to tackle with the consequences of the SV phenomenon by promoting a debate in healthcare to learn from other industries.

CB2. To bridge management, social, legal, educational, and clinical expertise to further develop the theoretical conceptualisation of the second victim phenomenon.

Deliverables

Paper. Systematic review of interventions conducted in other industries.
Paper. Review of proven interventions aimed at supporting second victims

Members

Albert Wu

Albert Wu

Johns Hopkins University- The Bloomberg School of Public Health

USA

Anna María Thordardottir

 

Iceland

Daniela Popovici

National School of Public Health, Management and Professional Development Bucharest

Romania

Georgeta Popovici

Georgeta Popovici

National School of Public Health, Management and Professional Development Bucharest

Romania

Ivana Tadić

University of Belgrade – Faculty of Pharmacy

Serbia

Kaja Põlluste

Kaja Põlluste

University of Tartu - Institute of Clinical Medicine

Estonia

Karolis Azukaitis

 

Lithuania

Kris Vanhaecht

Kris Vanhaecht

WG2 Leader

KU Leuven - University of Leuven

BELGIUM

Margit Lenk-Adusoo

Margit Lenk-Adusoo

Tartu Health Care College

Estonia

Martina Petrikova

Olomouc University - OlomoucUniversity [OUSHI]

Czech Republic

Massimiliano Panella

Massimiliano Panella

WG2 Leader

Università degli Studi del Piemonte Orientale UPO - Dipartimento di Medicina Traslazionale

ITALY

Mirabela Istrate

Mirabela Istrate

Babeș-Bolyai University, Faculty of Political, Administrative and Communication Sciences - Department of Public Health

Romania

Nebojša Stilinović

Nebojša Stilinović

Faculty of Medicine Novi Sad - Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology

Serbia

Pamela Tozzo

Pamela Tozzo

University of Padova

Italy

Patricia Luna Castaño

Patricia Luna Castaño

Quality Area, La Paz Carlos III Cantoblanco University Hospital

Spain

Peter Dieckmann

Capital Region of Denmark

Denmark

Peter Tavel

OUSHI - Palacký University

Czech Republic

Phillipe Michel

Phillipe Michel

Université Lyon 1 - Reshape research U1290 Inserm uni

France

Raluca Sfetcu

Spiru Haret University

Romania

Reinhard Strametz

Reinhard Strametz

Action Vice Chair

Wiesbaden Business School, RheinMain University of Applied Science and German Coalition for Patient Safety

GERMANY

Rianne Wennekes

Rianne Wennekes

Stichting Zuyderland Medisch Centrum

Netherlands

Seval Kul

Seval Kul

Gaziantep University Faculty of Medicine Department of Biostatistics

Turkey

Sigurbjorg Sigurgeirsdottir

University of Iceland

Iceland

Silvia Gabriela Scintee

Silvia Gabriela Scintee

Scoala Nationala de Sanatate Publica Management si Perfectionare in Domeniul Sanitar

Romania

Şule Kurt

Şule Kurt

Health Sciences Faculty, Karadeniz Technical University

Turkey

Veronica Lindström

Veronica Lindström

Karolinska Insititutet, Department of Neurobiology, Care Sciences and Society, section of nursing.

Suecia

Zdeněk Meier

Palacky University Olomouc

Czech Republic

WG3 - Making it Happen

Make feasible interventions, train professionals, and implement cultural, legal or educational changes

Objectives

RC6. Introducing new metrics on the system level that should be used to improve health workforce policy.

RC8. Agreeing what to do after occurring adverse events, sharing knowledge about research evidence and methods to tackle with this phenomenon, progressing beyond the state of the art and promoting innovation.

CB4. To create a network for the integration of fragmented initiatives, identifying more effective measures, applying lessons learned and to foster knowledge exchange and dissemination of research results.

CB5. To encourage the development of proposals to support second victims by overcoming the current fragmentation of rules, approaches, and policies, including experiences from other industries.

Deliverables

  • Case Study.
  • Training Manual.
  • Paper. Observational study on approaches to address the second victim phenomenon in Europe.
  • Technical Report on analysis of interventions implemented in participating countries to address the second victim’s phenomenon.

Members

Ahmed Novo

Medical Faculty UNSA

Bosnia and Herzegovina

Andrea Madarasova Geckova

Andrea Madarasova Geckova

Pavol Jozef Safarik University in Kosice, Medical faculty

Slovakia

Augustina Jankauskiene

Vilnius university hospital Sanatros klinikos

Lithuania

Basia Kutryba

Basia Kutryba

Towarzystwo Promocji Jakosci Opieki Zdrowotnej w Polsce (Polish Society for Quality in Healthcare Promotion in Poland) TPJ

Poland

Berglind Guðmundsdóttir

Iceland

Bojana Knezevic

Bojana Knezevic

STSM Coordinator

University Hospital Centre Zagreb

CROATIA

David Schwappach

David Schwappach

Swiss Patient Safety Foundation and Institute of Social and Preventive Medicine, University Bern

Switzerland

Elísabet Benedikz

 

Iceland

Gerhard Ohrband

 

Moldova

Gunnar Tschudi Bondevik

Gunnar Tschudi Bondevik

Department of global public health and primary care, University of Bergen

Norway

Halina Kutaj-Wasikowska

 

Poland

Ivan Humenik

Slovakia

Jesús María Aranaz

Jesús María Aranaz

Ramon y Cajal University Hospital

Spain

Katarina Stavrikj

Katarina Stavrikj

Medical Faculty, University Ss Cyril and Methodius Skopje

North Macedonia

Kristiina Helminem

Kristiina Helminem

LAB University of Applied Sciences, Health Care Unit

Finland

Mari Liukka

 

Finland

Marina Odalovic

 

Serbia

Miriam Abslöscher

Miriam Abslöscher

Wiener Gesundheitsverbund – Klinik Hietzing

Austria

Neda Milevska Kostova

Neda Milevska Kostova

Institute for Social Innovation

North Macedonia

Paulo Sousa

Paulo Sousa

WG3 Leader

National School of Public Health Universidade Nova de Lisboa

PORTUGAL

Pinar Ayvat

Pinar Ayvat

Izmir Democracy University Medical Faculty Anesthesia and Reanimation Department

Turkey

Rafal Nizankowski

 

Poland

Saša Vukmirović

 

Serbia

Savka Strbac

Public Health Institute of the Republic of Srpska

Bosnia and Herzegovina

Sofia Guerra Paiva

Sofia Guerra Paiva

Training School

National School of Public Health , University of Lisbon

PORTUGAL

Susana Lorenzo

Hospital Universitario Fundacion Alcorcon ,Quality and Patient Management

Spain

Susanna Tella

Susanna Tella

Science Communication Manager

LAB University of Applied Sciences, Multidisciplinary BIOPROT research team aiming to develop sustainable personal protective equipment (PPE) ecosystem, Sharing Learning from Practice to Improve Patient Safety (SLIPPS, www.slipps.eu) research team

FINLAND

Veli-Jukka Anttila

Finland

Wojciech Szot

 

Poland

WG4 - Facilitators and barriers

Explore and facilitate alternatives to overcome taboos, or obstacles facilitating collaboration among stakeholders

Objectives

RC4. Achieving changes in rules and regulations facilitating discussion of the legal, ethical, and organisational gaps while promoting a common understanding of factors underlying the interventions designed to support second victims.

RC7. Encouraging inclusion of the consequences of mistakes on care providers and the implications for health sciences in the field studies curricula.

CB1. To lead a debate to promote a culture of transparency and legal certainty as a contribution to furthering the wellbeing of frontline medical staff as part of its commitment to quality assurance.

Deliverables

  • White paper. Analysis of gaps training healthcare workforce.
  • Paper. Observational study based on qualitative techniques on the main gaps in the health professions’ curriculum to incorporate patient safety into training requirements across Europe.

Members

Anat Rafaeli

Anat Rafaeli

Technion - Israel Institute of Technology

Israel

Andreas Pitz

Hochschule Mannheim - University of Applied Sciences

Germany

Artiom Jucov

 

Moldova

Einav Srulovici

Einav Srulovici

WG4 Leader

University of Haifa

Israel

Erika Kubiliene

Vilniaus kolegija/University of Applied Sciences

Lithuania

Helga Bragadóttir

Helga Bragadóttir

University of Iceland and Landspitali University Hospital

Iceland

Hrefna Gunnarsdóttir

Hrefna Gunnarsdóttir

Center for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Iceland

Hüseyin Yadigaroğlu

Turkey

Ivana Skoumalova

Ivana Skoumalova

Pavol Jozef Safarik University

Slovakia

Katarina Stavrikj

Katarina Stavrikj

Medical Faculty, University Ss Cyril and Methodius Skopje

North Macedonia

Lieke Alberts

 

Netherlands

Lucia Prihodova

Lucia Prihodova

Royal College of Physicians of Ireland

IRELAND

Mary Tumelty

Mary Tumelty

University College Cork

Ireland

Matthias Raspe

Matthias Raspe

Charité - University Medicine Berlin,Dpt. for Infectious Diseases and Pneumology

Germany

Mery González Delgado

Mery González Delgado

Red de Conocimiento de Seguridad del Paciente

Colombia

Neda Milevska Kostova

Neda Milevska Kostova

Institute for Social Innovation

North Macedonia

Peter Bandura

Faculty of Medecine of Commenius University - Faculty of Medecine of Cumenius University [Institute of Social Medecine and Medical Ethics]

Slovakia

Romuald Krajewski

Maria Sklodowska-Curie National Research Institute of Oncology

Poland

Sandra Buttigieg

Sandra Buttigieg

WG4 Leader

University of Malta,Department of Health Services Management,Faculty of Health Sciences, Mater Dei Hospital

MALTA

Steven Lierman

KU Leuven

Belgium

Valentina Marinkovic

Valentina Marinkovic

University of Belgrade, Faculty of Pharmacy, Head of the Department of Social Pharmacy and Pharmaceutical

Serbia

Yolanda Agra

Yolanda Agra

Ministry of Health, Social Services and Equality

Spain

Žymantė Jankauskienė

 

Lithuania

This website use cookies to ensure you get the best experience on our website. By using our website you agree to our use of cookies.